StockData
Bionano Genomics, Inc. logo

Bionano Genomics, Inc. (BNGO) stock

BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)

Close on Nov 17, 2026Market cap $11.21MP/E –Yield –

Bionano Genomics r&d expenses

Research and development expenses are spending on new products and technology.

Bionano Genomics's R&D Expenses for the twelve months ending Jun 30, 2026 was $12.20M, down 9.6% year over year. For fiscal 2025 it was $11.37M, down 54.1% from the year before. The highest annual figure on record is $54.03M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.37M-54.1%
FY2024Dec 31, 2024$24.80M-54.1%
FY2023Dec 31, 2023$54.03M+10.2%
FY2022Dec 31, 2022$49.05M+118.1%
FY2021Dec 31, 2021$22.49M+119.2%
FY2020Dec 31, 2020$10.26M+12.9%
FY2019Dec 31, 2019$9.08M-4.3%
FY2018Dec 31, 2018$9.48M-21.0%
FY2017Dec 31, 2017$12.01M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.99M+1.9%
Q1 FY2026Mar 31, 2026$3.14M+32.4%
Q4 FY2025Dec 31, 2025$3.23M-7.1%
Q3 FY2025Sep 30, 2025$2.84M-39.7%
Q2 FY2025Jun 30, 2025$2.93M-57.1%
Q1 FY2025Mar 31, 2025$2.37M-75.8%
Q4 FY2024Dec 31, 2024$3.47M-70.3%
Q3 FY2024Sep 30, 2024$4.72M-65.8%
Q2 FY2024Jun 30, 2024$6.83M-53.2%
Q1 FY2024Mar 31, 2024$9.78M-29.8%
Q4 FY2023Dec 31, 2023$11.70M-16.5%
Q3 FY2023Sep 30, 2023$13.79M+8.2%
Q2 FY2023Jun 30, 2023$14.61M+24.2%
Q1 FY2023Mar 31, 2023$13.94M+32.4%
Q4 FY2022Dec 31, 2022$14.01M+52.0%
Q3 FY2022Sep 30, 2022$12.74M+95.9%
Q2 FY2022Jun 30, 2022$11.77M+188.0%
Q1 FY2022Mar 31, 2022$10.53M+293.1%
Q4 FY2021Dec 31, 2021$9.22M+220.3%
Q3 FY2021Sep 30, 2021$6.51M+182.3%
Q2 FY2021Jun 30, 2021$4.09M+70.2%
Q1 FY2021Mar 31, 2021$2.68M+0.1%
Q4 FY2020Dec 31, 2020$2.88M+19.9%
Q3 FY2020Sep 30, 2020$2.30M+6.0%
Q2 FY2020Jun 30, 2020$2.40M-0.3%
Q1 FY2020Mar 31, 2020$2.67M+27.3%
Q4 FY2019Dec 31, 2019$2.40M-4.9%
Q3 FY2019Sep 30, 2019$2.17M-13.2%
Q2 FY2019Jun 30, 2019$2.41M+14.7%
Q1 FY2019Mar 31, 2019$2.10M-11.3%
Q4 FY2018Dec 31, 2018$2.52M+2.6%
Q3 FY2018Sep 30, 2018$2.51M-15.6%
Q2 FY2018Jun 30, 2018$2.10M–
Q1 FY2018Mar 31, 2018$2.37M–
Q4 FY2017Dec 31, 2017$2.46M–
Q3 FY2017Sep 30, 2017$2.97M–

More Bionano Genomics figures

See a number that looks wrong?